Viewing Study NCT01356992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:36 PM
Ignite Modification Date: 2026-01-01 @ 8:51 AM
Study NCT ID: NCT01356992
Status: TERMINATED
Last Update Posted: 2015-06-18
First Post: 2011-05-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation
Sponsor: Eurofarma Laboratorios S.A.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non ST Segment Elevation Myocardial Infarction View
None Unstable Angina View
Keywords:

Keywords

Keyword Brief Keyword Text View
None non-inferiority phase III study View
None Low-Molecular Weight Heparin View
None Versa® (enoxaparin - Eurofarma) View
None Clexane® (enoxaparin - Sanofi-Aventis) View
None Acute coronary syndrome without ST-segment elevation View